SCHEMBL2716239

SCHEMBL2716239

CC(C)Oc1cnc(C(=O)O)c(Cl)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRKAB2 O43741 1/20 0.47
PRKAG1 P54619 1/20 0.47
PRKAA2 P54646 1/20 0.47
PRKAA1 Q13131 1/20 0.47
PRKAG3 Q9UGI9 1/20 0.47
PRKAG2 Q9UGJ0 1/20 0.47
PRKAB1 Q9Y478 1/20 0.47
ALDH1A1 P00352 2/20 0.44
ACACB O00763 3/20 0.43
KMT2A Q03164 2/20 0.42
KMO O15229 2/20 0.39
EGLN1 Q9GZT9 1/20 0.39
TDP1 Q9NUW8 1/20 0.38
RXRA P19793 1/20 0.38
RXRB P28702 1/20 0.38
MCL1 Q07820 1/20 0.38
MEN1 O00255 1/20 0.37
KDM4E B2RXH2 1/20 0.37
NSD2 O96028 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL362634 0.84 KMT2A (0.46) ALDH1A1KMT2ATDP1MEN1FFAR4
SCHEMBL27659789 0.82 ALDH1A1 (0.45) PRKAB2PRKAG1PRKAA2PRKAA1PRKAG3
SCHEMBL8516137 0.81 MAPT (0.42) PRKAB2PRKAG1PRKAA2PRKAA1PRKAG3
SCHEMBL2890712 0.79 ALDH1A1 (0.42) PRKAB2PRKAG1PRKAA2PRKAA1PRKAG3
SCHEMBL14720900 0.79 TDP1 (0.45) PRKAB2PRKAG1PRKAA2PRKAA1PRKAG3
SCHEMBL10324616 0.77 TDP1 (0.38) PRKAB2PRKAG1PRKAA2PRKAA1PRKAG3
SCHEMBL31430800 0.77 ALDH1A1 (0.56) PRKAB2PRKAG1PRKAA2PRKAA1PRKAG3
SCHEMBL1547204 0.75 MAP4K4 (0.41) ALDH1A1ACACB
SCHEMBL360439 0.75 TDP1 (0.39) PRKAB2PRKAG1PRKAA2PRKAA1PRKAG3
SCHEMBL14721176 0.75 BACE1 (0.41) ACACBKMT2AKMOTDP1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103403004-B Pyrrolopyrazine-spirocyclic piperidine amides as modulators of ion channels VERTEX PHARMACEUTICALS INC. (US) 2016-06-01 CN disclosed
EP-2445891-A1 5-MEMBERED HETEROARYL DERIVATIVES USED AS SPHINGOSINE 1-PHOSPHATE RECEPTOR AGONISTS Glaxo Group Limited (GB) 2012-05-02 EP disclosed
WO-2010148649-A1 5-MEMBERED HETEROARYL DERIVATIVES USED AS SPHINGOSINE 1-PHOSPHATE RECEPTOR AGONISTS GLAXO GROUP LIMITED (GB) 2010-12-29 WO disclosed